No abstract available
MeSH terms
- 2019-nCoV Vaccine mRNA-1273
- Amino Alcohols / adverse effects
- Amino Alcohols / chemistry
- Anaphylaxis / chemically induced*
- Anaphylaxis / diagnosis
- Anaphylaxis / pathology
- BNT162 Vaccine
- COVID-19 / immunology
- COVID-19 / pathology
- COVID-19 / prevention & control*
- COVID-19 / virology
- COVID-19 Vaccines / administration & dosage
- COVID-19 Vaccines / adverse effects*
- COVID-19 Vaccines / chemistry
- Decanoates / adverse effects
- Decanoates / chemistry
- Excipients / adverse effects
- Excipients / chemistry
- Humans
- Liposomes / administration & dosage
- Liposomes / adverse effects*
- Liposomes / immunology
- Mass Vaccination / statistics & numerical data
- Nanoparticles / administration & dosage
- Nanoparticles / adverse effects*
- Polyethylene Glycols / adverse effects
- Polyethylene Glycols / chemistry
- SARS-CoV-2 / pathogenicity
- Vaccines, Synthetic / administration & dosage
- Vaccines, Synthetic / adverse effects*
- Vaccines, Synthetic / chemistry
- mRNA Vaccines
Substances
- Amino Alcohols
- COVID-19 Vaccines
- Decanoates
- Excipients
- Lipid Nanoparticles
- Liposomes
- Vaccines, Synthetic
- Polyethylene Glycols
- DMG-PEG 2000
- (4-hydroxybutyl)azanediyl)bis(hexane-6,1-diyl)bis(2-hexyldecanoate)
- 2019-nCoV Vaccine mRNA-1273
- BNT162 Vaccine